Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...

The following is a summary of “Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant ...

Ketamine’s promising potential to ease depression is one of the reasons why its use has recently skyrocketed in the US and ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

Elon Musk said in a March 2024 interview that he takes ketamine to treat depression. He claimed to have a doctor's prescription for the drug. How often, or under what circumstances, he uses ketamine ...

When used properly in a clinical setting, ketamine has shown promise in treating major depression. It can also rapidly reduce suicidal thoughts and relieve other serious symptoms of depression.

Esketamine, the ketamine-derived nasal spray sold under the brand name Spravato (esketamine), is indicated for patients with treatment-resistant depression. In October 2023, the FDA warned about ...

In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...